PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

Steven B. Deitelzweig, MD, MMM, SFHM, FACP, FACC - Demystifying the Real-World Evidence in Atrial Fibrillation: A Comparative Look at the Direct Oral Anticoagulants for Reducing the Risk of Stroke Amo

02.28.2020 - By PVI, PeerView Institute for Medical EducationPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Go online to PeerView.com/NNV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in hospital and vascular medicine discusses how real-world data enhance the data from randomized clinical trials on direct oral anticoagulants (DOACs) for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) and offers insight on applying evidence from both real-world studies and randomized clinical trials to improve patient care. Upon completion of this activity, participants will be able to: Identify the role of real-world data and evidence in augmenting the efficacy and safety data that have been collected as part of clinical trials for stroke prevention among patients with NVAF, Compare and contrast evidence collected to date from real-world studies with data reported from clinical trials of DOACs to prevent stroke among patients with NVAF, Apply evidence from real-world studies and clinical trials of DOACs in patients with NVAF

More episodes from PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast